Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Staphylococcus aureus | 51 | 2025 | 1429 | 6.710 |
Why?
|
Staphylococcal Infections | 35 | 2025 | 1396 | 4.500 |
Why?
|
Bacterial Capsules | 20 | 2025 | 247 | 3.470 |
Why?
|
Staphylococcal Vaccines | 11 | 2021 | 30 | 3.310 |
Why?
|
Polysaccharides, Bacterial | 14 | 2019 | 582 | 2.200 |
Why?
|
Virulence Factors | 5 | 2024 | 498 | 1.390 |
Why?
|
Antibodies, Bacterial | 10 | 2021 | 1477 | 1.050 |
Why?
|
Bacterial Proteins | 18 | 2024 | 3833 | 0.980 |
Why?
|
Bacterial Toxins | 4 | 2021 | 922 | 0.960 |
Why?
|
Coagulase | 3 | 2016 | 53 | 0.890 |
Why?
|
Staphylococcal Skin Infections | 6 | 2021 | 78 | 0.860 |
Why?
|
Cell Wall | 5 | 2025 | 419 | 0.720 |
Why?
|
Teichoic Acids | 3 | 2025 | 70 | 0.700 |
Why?
|
Antigens, Bacterial | 6 | 2016 | 1148 | 0.690 |
Why?
|
Cytotoxins | 1 | 2018 | 154 | 0.570 |
Why?
|
Bacterial Vaccines | 3 | 2016 | 400 | 0.570 |
Why?
|
Bacteremia | 7 | 2017 | 987 | 0.540 |
Why?
|
Hemolysin Proteins | 1 | 2016 | 113 | 0.540 |
Why?
|
Abscess | 5 | 2016 | 606 | 0.510 |
Why?
|
Immunization, Passive | 5 | 2016 | 618 | 0.500 |
Why?
|
Soft Tissue Infections | 1 | 2016 | 166 | 0.470 |
Why?
|
Inflammasomes | 1 | 2020 | 541 | 0.470 |
Why?
|
Wound Infection | 1 | 2016 | 244 | 0.460 |
Why?
|
Anti-Bacterial Agents | 11 | 2021 | 7475 | 0.440 |
Why?
|
Virulence | 8 | 2024 | 1294 | 0.440 |
Why?
|
Surgical Wound Infection | 3 | 2016 | 1547 | 0.440 |
Why?
|
Cross Reactions | 1 | 2014 | 826 | 0.400 |
Why?
|
Neutrophils | 7 | 2021 | 3782 | 0.400 |
Why?
|
Bacterial Adhesion | 3 | 2015 | 306 | 0.390 |
Why?
|
Staphylococcus haemolyticus | 2 | 2007 | 6 | 0.370 |
Why?
|
Polysaccharides | 2 | 2019 | 1020 | 0.370 |
Why?
|
Methicillin-Resistant Staphylococcus aureus | 4 | 2022 | 705 | 0.360 |
Why?
|
Staphylococcus | 1 | 2010 | 145 | 0.340 |
Why?
|
Macrophages | 3 | 2021 | 5784 | 0.330 |
Why?
|
Fibrinogen | 2 | 2016 | 893 | 0.320 |
Why?
|
Antibodies, Neutralizing | 2 | 2021 | 2011 | 0.320 |
Why?
|
Mice | 27 | 2023 | 81898 | 0.310 |
Why?
|
Chemokines, CXC | 2 | 2008 | 420 | 0.300 |
Why?
|
CD4-Positive T-Lymphocytes | 4 | 2013 | 4410 | 0.300 |
Why?
|
Animals | 36 | 2024 | 168939 | 0.290 |
Why?
|
Bacterial Load | 3 | 2017 | 155 | 0.290 |
Why?
|
Sepsis | 2 | 2018 | 2604 | 0.270 |
Why?
|
Gastrointestinal Diseases | 1 | 2015 | 1203 | 0.270 |
Why?
|
Glycoproteins | 1 | 2013 | 2201 | 0.260 |
Why?
|
Vaccines, Subunit | 2 | 2016 | 159 | 0.260 |
Why?
|
Adhesins, Bacterial | 1 | 2006 | 118 | 0.250 |
Why?
|
N-Acetylmuramoyl-L-alanine Amidase | 2 | 2016 | 48 | 0.250 |
Why?
|
Pulmonary Surfactant-Associated Protein D | 1 | 2025 | 49 | 0.240 |
Why?
|
Disease Models, Animal | 15 | 2021 | 18329 | 0.240 |
Why?
|
Opsonin Proteins | 3 | 2016 | 144 | 0.240 |
Why?
|
Mannose-Binding Lectins | 1 | 2025 | 100 | 0.230 |
Why?
|
Diabetes Complications | 1 | 2011 | 1319 | 0.230 |
Why?
|
Gene Expression Regulation, Bacterial | 6 | 2019 | 1137 | 0.230 |
Why?
|
Vaccines, Synthetic | 3 | 2016 | 620 | 0.220 |
Why?
|
Immunoglobulins, Intravenous | 1 | 2008 | 668 | 0.220 |
Why?
|
Mannose-Binding Lectin | 1 | 2025 | 146 | 0.220 |
Why?
|
Phagocytosis | 3 | 2016 | 1526 | 0.220 |
Why?
|
Membrane Proteins | 2 | 2023 | 7869 | 0.220 |
Why?
|
Nasal Mucosa | 1 | 2006 | 416 | 0.210 |
Why?
|
Diabetes Mellitus, Experimental | 1 | 2008 | 1121 | 0.200 |
Why?
|
Rabbits | 5 | 2021 | 4752 | 0.200 |
Why?
|
Skin Diseases | 1 | 2010 | 1084 | 0.190 |
Why?
|
Host-Pathogen Interactions | 2 | 2021 | 1466 | 0.190 |
Why?
|
Diabetic Foot | 1 | 2005 | 382 | 0.190 |
Why?
|
Escherichia coli | 1 | 2013 | 4211 | 0.190 |
Why?
|
Lectins, C-Type | 1 | 2025 | 592 | 0.190 |
Why?
|
Vaccines, Conjugate | 4 | 2017 | 334 | 0.180 |
Why?
|
Erythromycin | 1 | 2021 | 114 | 0.180 |
Why?
|
Blood Bactericidal Activity | 2 | 2014 | 124 | 0.180 |
Why?
|
Osmotic Pressure | 1 | 2021 | 136 | 0.180 |
Why?
|
Mice, Inbred ICR | 2 | 2014 | 361 | 0.170 |
Why?
|
Membrane Fluidity | 1 | 2020 | 67 | 0.170 |
Why?
|
HL-60 Cells | 1 | 2021 | 364 | 0.170 |
Why?
|
Mastitis | 3 | 2016 | 41 | 0.170 |
Why?
|
Immunity, Innate | 3 | 2025 | 3079 | 0.170 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2011 | 4349 | 0.170 |
Why?
|
Pore Forming Cytotoxic Proteins | 1 | 2020 | 129 | 0.170 |
Why?
|
Carbohydrate Sequence | 2 | 2010 | 411 | 0.160 |
Why?
|
Peptidoglycan | 2 | 2018 | 246 | 0.160 |
Why?
|
Amyloid | 1 | 2023 | 849 | 0.150 |
Why?
|
Mice, Inbred BALB C | 5 | 2021 | 6225 | 0.150 |
Why?
|
Survival Analysis | 4 | 2018 | 10101 | 0.140 |
Why?
|
Cell Survival | 2 | 2021 | 5749 | 0.140 |
Why?
|
Blood Platelets | 1 | 2007 | 2465 | 0.130 |
Why?
|
Adjuvants, Immunologic | 3 | 2017 | 996 | 0.130 |
Why?
|
Multigene Family | 3 | 2019 | 1081 | 0.130 |
Why?
|
Cystic Fibrosis | 2 | 2016 | 1285 | 0.130 |
Why?
|
Pneumonia, Staphylococcal | 2 | 2013 | 39 | 0.130 |
Why?
|
Sphingomyelin Phosphodiesterase | 1 | 2016 | 83 | 0.130 |
Why?
|
Microvilli | 1 | 2016 | 234 | 0.130 |
Why?
|
Endocytosis | 1 | 2020 | 951 | 0.120 |
Why?
|
Apoptosis | 1 | 2011 | 9514 | 0.120 |
Why?
|
Lipoproteins | 1 | 2020 | 871 | 0.120 |
Why?
|
Cross Protection | 1 | 2014 | 25 | 0.120 |
Why?
|
Drug Compounding | 1 | 2016 | 236 | 0.120 |
Why?
|
rhoA GTP-Binding Protein | 1 | 2016 | 234 | 0.120 |
Why?
|
Cell Membrane | 1 | 2024 | 3642 | 0.120 |
Why?
|
Hydro-Lyases | 1 | 2014 | 93 | 0.110 |
Why?
|
Biofilms | 3 | 2022 | 641 | 0.110 |
Why?
|
Temperature | 1 | 2021 | 2231 | 0.110 |
Why?
|
Mice, Inbred C57BL | 7 | 2016 | 22351 | 0.110 |
Why?
|
Microbial Sensitivity Tests | 6 | 2021 | 1972 | 0.110 |
Why?
|
Hindlimb | 2 | 2006 | 513 | 0.110 |
Why?
|
Carrier State | 2 | 2016 | 530 | 0.110 |
Why?
|
Biological Therapy | 1 | 2015 | 140 | 0.110 |
Why?
|
Glycoconjugates | 1 | 2013 | 88 | 0.110 |
Why?
|
Biosynthetic Pathways | 1 | 2014 | 138 | 0.110 |
Why?
|
Microbial Viability | 1 | 2014 | 236 | 0.110 |
Why?
|
Glycerophosphates | 1 | 2013 | 51 | 0.110 |
Why?
|
Osteomyelitis | 2 | 2016 | 408 | 0.110 |
Why?
|
Adaptation, Biological | 1 | 2013 | 147 | 0.100 |
Why?
|
Molecular Sequence Data | 5 | 2010 | 17609 | 0.100 |
Why?
|
Genetic Engineering | 1 | 2018 | 936 | 0.100 |
Why?
|
Cells, Cultured | 4 | 2020 | 18986 | 0.100 |
Why?
|
Leukocidins | 2 | 2008 | 18 | 0.100 |
Why?
|
Pseudomonas aeruginosa | 2 | 2014 | 1276 | 0.100 |
Why?
|
Placebos | 1 | 2016 | 1659 | 0.090 |
Why?
|
Exotoxins | 2 | 2008 | 123 | 0.090 |
Why?
|
Bacteriophages | 1 | 2015 | 382 | 0.090 |
Why?
|
Endopeptidases | 1 | 2015 | 762 | 0.090 |
Why?
|
Microscopy, Confocal | 3 | 2016 | 1969 | 0.090 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2016 | 1331 | 0.090 |
Why?
|
Genes, Bacterial | 3 | 2006 | 1076 | 0.090 |
Why?
|
Vaccination | 2 | 2018 | 3435 | 0.090 |
Why?
|
Vancomycin | 1 | 2013 | 504 | 0.080 |
Why?
|
Microscopy, Atomic Force | 1 | 2010 | 250 | 0.080 |
Why?
|
Humans | 26 | 2025 | 766812 | 0.080 |
Why?
|
Oxidative Stress | 1 | 2021 | 3139 | 0.080 |
Why?
|
Electrolytes | 1 | 2010 | 279 | 0.080 |
Why?
|
Gentamicins | 1 | 2010 | 244 | 0.080 |
Why?
|
Magnetic Resonance Spectroscopy | 2 | 2010 | 3681 | 0.080 |
Why?
|
Proteomics | 1 | 2023 | 3915 | 0.080 |
Why?
|
Epithelial Cells | 1 | 2021 | 3698 | 0.080 |
Why?
|
Epitopes | 1 | 2014 | 2526 | 0.070 |
Why?
|
Microscopy, Immunoelectron | 1 | 2007 | 316 | 0.070 |
Why?
|
Methicillin Resistance | 1 | 2008 | 198 | 0.070 |
Why?
|
Recombinant Fusion Proteins | 1 | 2016 | 3738 | 0.070 |
Why?
|
Genetic Complementation Test | 3 | 2015 | 556 | 0.070 |
Why?
|
Immunoglobulin G | 2 | 2016 | 4559 | 0.070 |
Why?
|
Receptors, Leptin | 1 | 2008 | 352 | 0.070 |
Why?
|
Operon | 2 | 2019 | 371 | 0.070 |
Why?
|
Rats, Wistar | 2 | 2013 | 1887 | 0.070 |
Why?
|
Antibodies, Monoclonal | 3 | 2016 | 9244 | 0.070 |
Why?
|
Membrane Transport Proteins | 1 | 2012 | 1029 | 0.070 |
Why?
|
Cattle | 3 | 2008 | 3815 | 0.070 |
Why?
|
Microfluidic Analytical Techniques | 1 | 2012 | 789 | 0.070 |
Why?
|
Genome, Bacterial | 2 | 2015 | 796 | 0.060 |
Why?
|
Female | 15 | 2021 | 396532 | 0.060 |
Why?
|
Mice, Mutant Strains | 1 | 2008 | 1751 | 0.060 |
Why?
|
Vaccines, Inactivated | 1 | 2006 | 186 | 0.060 |
Why?
|
Promoter Regions, Genetic | 3 | 2019 | 5795 | 0.060 |
Why?
|
Respiratory Burst | 1 | 2005 | 110 | 0.060 |
Why?
|
Growth Inhibitors | 1 | 2006 | 375 | 0.060 |
Why?
|
Intestinal Mucosa | 1 | 2016 | 3041 | 0.060 |
Why?
|
Rats, Sprague-Dawley | 1 | 2016 | 8108 | 0.060 |
Why?
|
Serotyping | 1 | 2005 | 331 | 0.060 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2008 | 12246 | 0.060 |
Why?
|
Keratins | 1 | 2006 | 499 | 0.060 |
Why?
|
Community-Acquired Infections | 1 | 2008 | 470 | 0.060 |
Why?
|
Administration, Intranasal | 1 | 2006 | 482 | 0.060 |
Why?
|
Mammary Glands, Animal | 1 | 2005 | 273 | 0.060 |
Why?
|
Receptors, Pattern Recognition | 1 | 2025 | 81 | 0.060 |
Why?
|
Enzyme Inhibitors | 1 | 2014 | 3723 | 0.050 |
Why?
|
Family Health | 1 | 2008 | 1254 | 0.050 |
Why?
|
Molecular Structure | 1 | 2007 | 1882 | 0.050 |
Why?
|
Complement C3 | 1 | 2005 | 434 | 0.050 |
Why?
|
Uridine Diphosphate Sugars | 1 | 2002 | 10 | 0.050 |
Why?
|
Uridine Diphosphate N-Acetylglucosamine | 1 | 2002 | 18 | 0.050 |
Why?
|
Cell Aggregation | 1 | 2022 | 238 | 0.050 |
Why?
|
Vitamin K 3 | 1 | 2021 | 14 | 0.050 |
Why?
|
Base Sequence | 3 | 2012 | 12415 | 0.050 |
Why?
|
Leukocytes, Mononuclear | 1 | 2008 | 1852 | 0.050 |
Why?
|
O Antigens | 1 | 2002 | 196 | 0.050 |
Why?
|
Rats | 4 | 2016 | 23717 | 0.050 |
Why?
|
Mice, Inbred NOD | 1 | 2005 | 1836 | 0.050 |
Why?
|
DNA, Bacterial | 1 | 2005 | 1477 | 0.040 |
Why?
|
Transcription, Genetic | 3 | 2019 | 7612 | 0.040 |
Why?
|
Point Mutation | 1 | 2006 | 1592 | 0.040 |
Why?
|
Urea | 1 | 2022 | 449 | 0.040 |
Why?
|
Antibodies | 1 | 2008 | 2421 | 0.040 |
Why?
|
Nose | 2 | 2015 | 522 | 0.040 |
Why?
|
Sequence Analysis, DNA | 2 | 2015 | 4780 | 0.040 |
Why?
|
Interferon-gamma | 1 | 2008 | 3157 | 0.040 |
Why?
|
Disease Outbreaks | 1 | 2008 | 1761 | 0.040 |
Why?
|
Disease Susceptibility | 1 | 2005 | 1791 | 0.040 |
Why?
|
RNA, Bacterial | 2 | 2015 | 393 | 0.040 |
Why?
|
Sigma Factor | 1 | 2019 | 177 | 0.040 |
Why?
|
Conserved Sequence | 2 | 2015 | 1159 | 0.040 |
Why?
|
Phenotype | 1 | 2015 | 16722 | 0.040 |
Why?
|
Glutamic Acid | 1 | 2022 | 1181 | 0.030 |
Why?
|
Flow Cytometry | 1 | 2007 | 5890 | 0.030 |
Why?
|
Hyperglycemia | 1 | 2005 | 1389 | 0.030 |
Why?
|
Immunization | 1 | 2021 | 1218 | 0.030 |
Why?
|
Repressor Proteins | 2 | 2019 | 2979 | 0.030 |
Why?
|
Signal Transduction | 1 | 2020 | 23618 | 0.030 |
Why?
|
Cell Line | 1 | 2010 | 15564 | 0.030 |
Why?
|
Complement C3b | 1 | 2016 | 98 | 0.030 |
Why?
|
Chromosomes, Bacterial | 2 | 2008 | 281 | 0.030 |
Why?
|
Mutation | 3 | 2016 | 30214 | 0.030 |
Why?
|
Cell Proliferation | 1 | 2010 | 10451 | 0.030 |
Why?
|
Suramin | 1 | 2014 | 34 | 0.030 |
Why?
|
Ceramides | 1 | 2016 | 202 | 0.030 |
Why?
|
Quorum Sensing | 1 | 2015 | 137 | 0.030 |
Why?
|
Ampicillin | 1 | 2014 | 138 | 0.030 |
Why?
|
Cell Movement | 1 | 2006 | 5204 | 0.030 |
Why?
|
Antigens, CD | 1 | 2025 | 4033 | 0.030 |
Why?
|
DNA Primers | 2 | 2012 | 2826 | 0.030 |
Why?
|
Hydrolysis | 1 | 2015 | 645 | 0.030 |
Why?
|
Salmonella typhimurium | 1 | 2016 | 348 | 0.030 |
Why?
|
Alum Compounds | 1 | 2013 | 35 | 0.030 |
Why?
|
Inhibitory Concentration 50 | 1 | 2014 | 464 | 0.030 |
Why?
|
Molecular Typing | 1 | 2013 | 115 | 0.030 |
Why?
|
Fungal Proteins | 1 | 1997 | 901 | 0.030 |
Why?
|
Immune Sera | 1 | 2013 | 605 | 0.030 |
Why?
|
Tetanus Toxoid | 1 | 2013 | 188 | 0.030 |
Why?
|
Clinical Trials as Topic | 1 | 2008 | 8045 | 0.030 |
Why?
|
Trans-Activators | 1 | 2002 | 2856 | 0.020 |
Why?
|
Immunomodulation | 1 | 2016 | 548 | 0.020 |
Why?
|
Kinetics | 2 | 2014 | 6288 | 0.020 |
Why?
|
Oligodeoxyribonucleotides | 1 | 2013 | 705 | 0.020 |
Why?
|
Male | 8 | 2021 | 364154 | 0.020 |
Why?
|
Binding Sites | 1 | 2019 | 6013 | 0.020 |
Why?
|
Culture Media | 1 | 2012 | 893 | 0.020 |
Why?
|
Static Electricity | 1 | 2010 | 258 | 0.020 |
Why?
|
Bronchi | 1 | 2013 | 847 | 0.020 |
Why?
|
Acetylglucosamine | 1 | 2010 | 188 | 0.020 |
Why?
|
Actins | 1 | 2016 | 2061 | 0.020 |
Why?
|
Methicillin | 1 | 2008 | 62 | 0.020 |
Why?
|
Fluorescent Dyes | 1 | 2016 | 1927 | 0.020 |
Why?
|
Bacterial Infections | 1 | 2016 | 1390 | 0.020 |
Why?
|
Stress, Mechanical | 1 | 2012 | 1674 | 0.020 |
Why?
|
Plasmids | 1 | 2012 | 2268 | 0.020 |
Why?
|
Protein Binding | 1 | 2019 | 9326 | 0.020 |
Why?
|
Adaptation, Physiological | 1 | 2013 | 1312 | 0.020 |
Why?
|
Gene Silencing | 1 | 2013 | 1505 | 0.020 |
Why?
|
Evolution, Molecular | 1 | 2015 | 1893 | 0.020 |
Why?
|
Synteny | 1 | 2005 | 77 | 0.020 |
Why?
|
Neutrophil Infiltration | 1 | 2008 | 392 | 0.020 |
Why?
|
Gene Order | 1 | 2005 | 166 | 0.020 |
Why?
|
Sequence Homology | 1 | 2005 | 197 | 0.020 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2012 | 3803 | 0.020 |
Why?
|
Staphylococcus epidermidis | 1 | 2005 | 121 | 0.020 |
Why?
|
Recombinant Proteins | 1 | 2015 | 6507 | 0.020 |
Why?
|
Gene Deletion | 1 | 2012 | 2669 | 0.010 |
Why?
|
Histocompatibility Antigens Class II | 1 | 2008 | 1442 | 0.010 |
Why?
|
Iron | 1 | 2012 | 1812 | 0.010 |
Why?
|
Up-Regulation | 1 | 2013 | 4143 | 0.010 |
Why?
|
Electrophoresis, Capillary | 1 | 2002 | 63 | 0.010 |
Why?
|
Genome-Wide Association Study | 1 | 2021 | 12808 | 0.010 |
Why?
|
DNA Transposable Elements | 1 | 2005 | 764 | 0.010 |
Why?
|
Cross Infection | 1 | 2010 | 1427 | 0.010 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2008 | 4570 | 0.010 |
Why?
|
Catalysis | 1 | 2002 | 767 | 0.010 |
Why?
|
Gene Rearrangement | 1 | 2005 | 1141 | 0.010 |
Why?
|
Gene Expression | 1 | 2013 | 7585 | 0.010 |
Why?
|
Nuclear Magnetic Resonance, Biomolecular | 1 | 2002 | 502 | 0.010 |
Why?
|
Biological Evolution | 1 | 2005 | 1075 | 0.010 |
Why?
|
Transcription Factors | 1 | 2019 | 12159 | 0.010 |
Why?
|
Genotype | 1 | 2013 | 13036 | 0.010 |
Why?
|
Treatment Outcome | 2 | 2016 | 65286 | 0.010 |
Why?
|
Drug Resistance, Bacterial | 1 | 2005 | 1065 | 0.010 |
Why?
|
Lymphocyte Activation | 1 | 2008 | 5502 | 0.010 |
Why?
|
Longitudinal Studies | 1 | 2013 | 14762 | 0.010 |
Why?
|
Sequence Analysis | 1 | 1997 | 240 | 0.010 |
Why?
|
Mass Spectrometry | 1 | 2002 | 2198 | 0.010 |
Why?
|
Lung | 1 | 2013 | 10068 | 0.010 |
Why?
|
Sequence Alignment | 1 | 1997 | 2177 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2008 | 14473 | 0.010 |
Why?
|
Child | 2 | 2013 | 80670 | 0.010 |
Why?
|
Biological Transport | 1 | 1997 | 2083 | 0.010 |
Why?
|
Cell Line, Tumor | 1 | 2008 | 17089 | 0.010 |
Why?
|
Chronic Disease | 1 | 2005 | 9358 | 0.010 |
Why?
|
RNA, Messenger | 1 | 2002 | 12795 | 0.000 |
Why?
|
Young Adult | 1 | 2013 | 59939 | 0.000 |
Why?
|
Adult | 2 | 2013 | 223305 | 0.000 |
Why?
|
Amino Acid Sequence | 1 | 1997 | 13411 | 0.000 |
Why?
|
Child, Preschool | 1 | 2008 | 42577 | 0.000 |
Why?
|
Adolescent | 1 | 2013 | 88902 | 0.000 |
Why?
|
Retrospective Studies | 1 | 2013 | 81657 | 0.000 |
Why?
|